First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, L.-S. Rathje et al.|Leukemia|2018Cited by 52
First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Ali Moshfegh et al.|Blood|2015Cited by 6
A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.Håkan Mellstedt, Ali Moshfegh, Salam Khan et al.|Journal of Clinical Oncology|2015Cited by 4